Can You Pay for Zepbound With an HSA or FSA in 2026? Receipts, IRS Rules, and Pharmacy Workarounds

You can use Health Savings Account (HSA) or Flexible Spending Account (FSA) funds to pay for a Zepbound prescription in 2026 as long as the drug is prescribed by a licensed provider, intended to treat obesity or diabetes, and you keep an IRS-compliant pharmacy receipt. The same rules generally apply to compounded tirzepatide when it is dispensed under a valid patient-specific prescription. Administrators may initially deny the swipe, but a detailed receipt or letter of medical necessity almost always overturns the decision.

• The IRS lists prescription medications-including weight-loss drugs-among qualified medical expenses in Publication 502 for tax year 2026.
• Your pharmacy receipt must show the Rx symbol, drug name (tirzepatide or Zepbound), date filled, prescription number, and the amount you paid after any coupons or insurance.
• IIAS pharmacy terminals auto-approve HSA/FSA cards when the National Drug Code (NDC) is flagged as eligible; some older systems still reject newly launched strengths like Zepbound 12.5 mg, so be prepared to submit the claim manually.
• Compounded tirzepatide qualifies only when prepared by a 503A pharmacy on a per-patient basis and there is no FDA-approved shortage alternative available in the exact strength your doctor prescribes.
• Keep documentation for at least three years: the IRS can ask you to substantiate any HSA or FSA withdrawal during an audit.

Why Zepbound Counts as a Qualified Medical Expense

Prescription drugs are expressly listed as qualified medical expenses in IRS Publication 502 and Publication 969. Because Zepbound (tirzepatide) is FDA-approved to treat obesity under NDC 0002-1501-11 through -15, it meets the definition when it is prescribed “to alleviate or prevent a physical or mental defect or illness.” Obesity is recognized by the American Medical Association as a chronic disease, so weight-loss indication alone is enough to satisfy the IRS requirement.

Off-label diabetes use: Some clinicians prescribe Zepbound for type 2 diabetes when Mounjaro is not available due to shortages. An off-label prescription still qualifies as long as the drug is legally dispensed and “primarily for medical care” rather than general well-being.

For a cost preview, see our Zepbound cost breakdown by dose or run the numbers yourself with the 12-month GLP-1 cost calculator.

IRS Documentation Rules You Must Follow

Administrators are merely gatekeepers; the IRS is the true decision maker. The agency has two bright-line requirements for prescription drug expenses:

1. Written prescription: The pharmacy label or e-prescription record satisfies this.

2. Payment record: A receipt must prove the amount and date paid.

Most administrators ask for the following fields:

• Patient name and address
• Rx symbol and prescription number
• Drug name and NDC
• Date filled and quantity
• Pharmacy name and address
• Amount paid after discounts such as the Rx.com discount card

How to Pay With an HSA/FSA Card at the Pharmacy

The easiest route is to swipe your HSA or FSA debit card at a pharmacy that supports the Inventory Information Approval System (IIAS). When the system reads an eligible NDC, it green-lights the transaction automatically.

Step-by-step at the counter:

• Tell the pharmacist you plan to use an HSA or FSA card.
• If the terminal rejects the card, ask if the pharmacy can override the IIAS code manually.
• Pay with an alternate card and request an itemized prescription receipt (sometimes called a “universal claim form” or UCF).
• Submit the receipt through your plan portal for reimbursement.

Using a coupon? You can still pay pre-tax. The IRS cares only about the actual dollars you spend. For deeper savings, compare the cash price on Rx.com before checkout-many patients pay $600 to $710 per 5 mg pen with a free discount card.

Free Receipt Template and Checklist

You can usually rely on the pharmacy’s built-in receipt, but independent or compound pharmacies may not print every required field. The following template covers everything an administrator needs.

Does Compounded Tirzepatide Qualify?

Compounded tirzepatide is not FDA-approved, but that alone does not disqualify it. The IRS focuses on whether the medication is “legally prescribed” and “for medical care.” According to IRS Chief Counsel Memorandum 201719025, compounded drugs are eligible if:

• They require a prescription from a licensed provider.
• They are not “merely cosmetic.”
• The compound pharmacy follows state board and 503A federal regulations.

Documentation tip: Request a letter of medical necessity (LMN) when filling compounded tirzepatide. Most administrators have a one-page form your prescriber can sign in minutes.

For more on compounded pricing, read our compounded tirzepatide cost analysis.

Common Claim Denials and How to Appeal

Even with perfect documentation, some claims hit roadblocks. Here are the most frequent denial codes and proven rebuttals:

“Non-qualified expense”: Attach IRS Publication 502 page 15 highlighting “Drugs that require a prescription” and resubmit.

“Cosmetic or general health”: Provide an LMN stating the ICD-10 code E66.9 (obesity).

“Receipt incomplete”: Use the template above, circle missing items, and ask the pharmacist to stamp and initial it.

If all else fails, escalate to the plan’s fiduciary committee. By law, they must provide a written final determination you can take to the Department of Labor for an ERISA appeal.